Analysis of the function of lymphocyte adhesion molecules and its clinical significances in autoimmune diseases

淋巴细胞粘附分子在自身免疫性疾病中的功能分析及其临床意义

基本信息

  • 批准号:
    13470107
  • 负责人:
  • 金额:
    $ 10.43万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2002
  • 项目状态:
    已结题

项目摘要

It has been repeated that the expression of b1 integrins and ligands are elevated in the inflammatory lesions in rheumatoid arthritis (RA), Crk-associated substrate lymphocyte type (Cas-L) is a docking protein that is heavily tyrosine phosphorylated by the engagement of β1 integrins in T cells.In the present study, we attempted to evaluate the role of Cas-L in the pathophysiology of rheumatoid arthritis (RA). We analyzed human T-lymphotropic virus type I (HTLV-I) tax transgenic mice, since they develop polyarthritis resembling human RA. Here we show that migratory activity of spleen cells from tax transgenic mice with arthritis (Atg) was much higher than that of tax transgenic mice without arthritis (Ntg) and littermate control mice (Ct). Biochemical studies revealed that Cas-L protein and its spontaneous tyrosine phosphorylation were increased in Atg mice compared to Ntg and Ct mice, which might be caused by activated fyn and lck. Immunohistochemical analysis showed a large number of Cas-L positive lymphocytes migrating into the affected joints. Finally, in human RA, Cas-L positive lymphocytes have been shown to infiltrate to the inflammatory lesions. The above results strongly suggest that Cas-L appears to play an important role in the pathophysiology of RA.
在类风湿关节炎(RA)的炎性病变中,β 1整合素和β 1配体的表达增加,Crk相关底物淋巴细胞型(Cas-L)是一种通过β1整合素参与T细胞酪氨酸磷酸化的对接蛋白,本研究试图探讨Cas-L在RA病理生理中的作用。我们分析了人类嗜T淋巴细胞病毒I型(HTLV-I)税收转基因小鼠,因为他们开发类似人类RA的多关节炎。在这里,我们表明,从tax转基因小鼠关节炎(Atg)的脾细胞的迁移活性远远高于无关节炎(Ntg)和同窝对照小鼠(Ct)的tax转基因小鼠。生化研究表明,与Ntg和Ct小鼠相比,Atg小鼠中的Cas-L蛋白及其自发酪氨酸磷酸化增加,这可能是由激活的fyn和lck引起的。免疫组化显示大量Cas-L阳性淋巴细胞迁移到受累关节。最后,在人类RA中,已显示Cas-L阳性淋巴细胞浸润至炎性病变。上述结果有力地表明,Cas-L似乎在RA的病理生理学中发挥重要作用。

项目成果

期刊论文数量(48)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Ouchida R, Kusuhara M, Shimizu N, Hisada T, Makino Y, Morimoto C, Handa H, Ohsuzu F, Tanaka H: "Suppression of NF-kappaB-dependent gene expression by a hexamethylene bisacetamide-inducible protein HEXIM1 in human vascular smooth muscle cells. Genes Cells"
Ouchida R、Kusuhara M、Shimizu N、Hisada T、Makino Y、Morimoto C、Handa H、Ohsuzu F、Tanaka H:“六亚甲基双乙酰胺诱导蛋白 HEXIM1 在人血管平滑肌中抑制 NF-kappaB 依赖性基因表达
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Suzuki T, Nakamoto T, Ogawa S, Seo S, Matsumura T, Tachibana K, Morimoto C, Hirai H: "MICAL, a novel CasL interacting molecule, associates with vimentin"J Biol Chem. 277. 14933-14941 (2002)
Suzuki T、Nakamoto T、Okawa S、Seo S、Matsumura T、Tachibana K、Morimoto C、Hirai H:“MICAL,一种新型 CasL 相互作用分子,与波形蛋白结合”J Biol Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
lwata S: "Distinctive signaling pathways through CD82 and β1 integrins in human T cells"Eur.J.Immunol. 32. 1328-1337 (2002)
Iwata S:“人 T 细胞中通过 CD82 和 β1 整合素的独特信号传导途径”Eur.J.Immunol. 32. 1328-1337 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hisakawa N, Tanaka H, Hosono O, Nishijima R, Ohashi Y, Saito S, Nishiya K, Hashimoto K, Morimoto C.: "Aberrant Responsiveness to RANTES in Synovial Fluid T cells ten Patients with Rheumatoid Arthritis"J. Rheumatol.. 29. 1124-1134 (2002)
Hisakawa N、Tanaka H、Hosono O、Nishijima R、Ohashi Y、Saito S、Nishiya K、Hashimoto K、Morimoto C.:“十名类风湿关节炎患者滑液 T 细胞对 RANTES 的异常反应”J。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hase H, Kanno Y, Kojima H, Morimoto C, Okumura K, Kobala T: "CD27 and CD40 inhibit p53-independent mitochondrial pathways in apoptosis of B cells induced by B cell receptor ligation"J Biol Chem. 277. 46950-46958 (2002)
Hase H、Kanno Y、Kojima H、Morimoto C、Okumura K、Kobala T:“CD27 和 CD40 在 B 细胞受体连接诱导的 B 细胞凋亡中抑制 p53 独立的线粒体途径”J Biol Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MORIMOTO Chikao其他文献

MORIMOTO Chikao的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MORIMOTO Chikao', 18)}}的其他基金

Association of deubiquitin ligase and cell surface molecules regulates the pathophysiology of malignant pleural mesothelioma
去泛素连接酶和细胞表面分子的关联调节恶性胸膜间皮瘤的病理生理学
  • 批准号:
    24659401
  • 财政年份:
    2012
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
To determine the epigenetic regulatory mechanism of cancer stem cells by cell surface molecules.
通过细胞表面分子确定癌症干细胞的表观遗传调控机制。
  • 批准号:
    22650223
  • 财政年份:
    2010
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Basic research of defining the function of CD26 on human immune system and its clinical application for autoimmune diseases.
CD26对人体免疫系统功能的基础研究及其在自身免疫性疾病中的临床应用。
  • 批准号:
    22390200
  • 财政年份:
    2010
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Basic Approach for the Development of Molecular Target Therapy for Autoimmune Diseases and Immune-Mediated Disorders.
开发自身免疫性疾病和免疫介导疾病分子靶向治疗的基本方法。
  • 批准号:
    17109011
  • 财政年份:
    2005
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (S)
Basic study of molecular target therapy for autoimmune diseases and immune deficiency diseases based on CD26
基于CD26的自身免疫性疾病及免疫缺陷病分子靶向治疗基础研究
  • 批准号:
    15209033
  • 财政年份:
    2003
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
The development of specific immune regulatory drugs utilizing the structure and function of CD26
利用CD26的结构和功能开发特异性免疫调节药物
  • 批准号:
    13557039
  • 财政年份:
    2001
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of CD29/VLA integrin in T cell immune regulation and its clinical significance
CD29/VLA整合素在T细胞免疫调节中的作用分析及其临床意义
  • 批准号:
    11307009
  • 财政年份:
    1999
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A).
Structure and function of memory T cell marker CD26
记忆T细胞标志物CD26的结构和功能
  • 批准号:
    11694248
  • 财政年份:
    1999
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Development of specific imuune regulatoly drugs by the cell surface molecules.
利用细胞表面分子开发特异性免疫调节药物。
  • 批准号:
    10557049
  • 财政年份:
    1998
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Analysis of CD26 mediated signal transduction mechanism.
CD26介导的信号转导机制分析。
  • 批准号:
    09044266
  • 财政年份:
    1997
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for international Scientific Research

相似海外基金

Analysis of metabolic regulation by polyhydroxybutyrate as a signal molecule in purple photosynthetic bacteria
聚羟基丁酸酯作为信号分子对紫色光合细菌的代谢调控分析
  • 批准号:
    20K15445
  • 财政年份:
    2020
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Pathology of aortic dissection with focal adhesion signal molecule FAK and breakthrough medicine development
粘着斑信号分子 FAK 的主动脉夹层病理学和突破性药物开发
  • 批准号:
    18K15867
  • 财政年份:
    2018
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Identification of signal molecule mediating anthocyanin biosynthesis during flower development in Eustoma
洋桔梗花发育过程中介导花青素生物合成信号分子的鉴定
  • 批准号:
    16K18655
  • 财政年份:
    2016
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Effect of bacterial signal molecule AI-2 on the metabolism and pathogenicity of protozoa
细菌信号分子AI-2对原虫代谢及致病性的影响
  • 批准号:
    16K19113
  • 财政年份:
    2016
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Analysis of signal molecule modifications by multidimensional flow cytometric method
多维流式细胞术分析信号分子修饰
  • 批准号:
    15K14459
  • 财政年份:
    2015
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Immune regulation of oral disease by co-signal molecule B7-H3 and the novel receptor.
共信号分子 B7-H3 和新型受体对口腔疾病的免疫调节。
  • 批准号:
    21592385
  • 财政年份:
    2009
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional analysis of a novel signal molecule CDCP1 which regulates anchorage-independent growth in cancer cells
调节癌细胞贴壁依赖性生长的新型信号分子CDCP1的功能分析
  • 批准号:
    21590350
  • 财政年份:
    2009
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a fat soluble signal molecule for cancer chemotherapy
开发用于癌症化疗的脂溶性信号分子
  • 批准号:
    19590027
  • 财政年份:
    2007
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of the function of isoleucine, a blood glucose-lowering amino acid, as the signal molecule that regulates glucose metabolism
降血糖氨基酸异亮氨酸作为调节糖代谢信号分子的功能分析
  • 批准号:
    19580133
  • 财政年份:
    2007
  • 资助金额:
    $ 10.43万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Quorum sensing signal molecule modulation of immunity: role in host responses to P. aeruginosa lung infection
免疫的群体感应信号分子调节:在宿主对铜绿假单胞菌肺部感染的反应中的作用
  • 批准号:
    nhmrc : 399704
  • 财政年份:
    2006
  • 资助金额:
    $ 10.43万
  • 项目类别:
    NHMRC Project Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了